name:-0.024475812911987
name:-0.013571977615356
name:-0.0032880306243896
Chen; Zecheng Patent Filings

Chen; Zecheng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Zecheng.The latest application filed is for "bifunctional cytotoxic agents containing the cti pharmacophore".

Company Profile
3.13.21
  • Chen; Zecheng - New City NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Bifunctional cytotoxic agents containing the CTI pharmacophore
Grant 11,365,263 - Maderna , et al. June 21, 2
2022-06-21
Bifunctional Cytotoxic Agents Containing The Cti Pharmacophore
App 20210061923 - MADERNA; Andreas ;   et al.
2021-03-04
Bifunctional cytotoxic agents containing the CTI pharmacophore
Grant 10,870,706 - Maderna , et al. December 22, 2
2020-12-22
Bifunctional cytotoxic agents
Grant 10,391,182 - Maderna , et al. A
2019-08-27
Bifunctional Cytotoxic Agents
App 20180339060 - MADERNA; Andreas ;   et al.
2018-11-29
Bifunctional cytotoxic agents
Grant 10,086,085 - Maderna , et al. October 2, 2
2018-10-02
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 10,022,381 - Venkatesan , et al. July 17, 2
2018-07-17
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20170224696 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2017-08-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20170119778 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2017-05-04
Bifunctional Cytotoxic Agents Containing The Cti Pharmacophore
App 20160271270 - MADERNA; Andreas ;   et al.
2016-09-22
Triazine compounds as PI3 kinase and MTOR inhibitors
Grant 9,174,963 - Venkatesan , et al. November 3, 2
2015-11-03
Bifunctional Cytotoxic Agents
App 20150209445 - MADERNA; Andreas ;   et al.
2015-07-30
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20150011752 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2015-01-08
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 8,859,542 - Venkatesan , et al. October 14, 2
2014-10-14
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20140248239 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2014-09-04
Triazine compounds as P13 kinase and MTOR inhibitors
Grant 8,748,421 - Venkatesan , et al. June 10, 2
2014-06-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20130315865 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2013-11-28
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 8,575,159 - Venkatesan , et al. November 5, 2
2013-11-05
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 8,445,486 - Venkatesan , et al. May 21, 2
2013-05-21
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20130109670 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2013-05-02
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20130005723 - Venkatesan; Aranapakam Mudumbai ;   et al.
2013-01-03
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 8,217,036 - Venkatesan , et al. July 10, 2
2012-07-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20110312955 - VENKATESAN; Aranapakam Mudumbai ;   et al.
2011-12-22
Triazine compounds as PI3 kinase and mTOR inhibitors
Grant 8,039,469 - Venkatesan , et al. October 18, 2
2011-10-18
Process For The Preparation Of 2,4-dichloro-7h-pyrrolo[2,3h]quinazoline
App 20100036123 - Kremer; Kenneth Alfred Martin ;   et al.
2010-02-11
(2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses
App 20100003250 - Chen; Zecheng ;   et al.
2010-01-07
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20090304692 - Venkatesan; Aranapakam Mudumbai ;   et al.
2009-12-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors
App 20090291079 - Venkatesan; Aranapakam Mudumbai ;   et al.
2009-11-26
7H-PYRROLO[2,3-H]QUINAZOLINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESIS
App 20090227575 - Venkatesan; Aranapakam Mudumbai ;   et al.
2009-09-10
3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
App 20090181963 - Dehnhardt; Christoph Martin ;   et al.
2009-07-16
PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORS
App 20090149458 - CHEN; Zecheng ;   et al.
2009-06-11
Amino-substituted Quinazoline Derivatives As Inhibitors Of Beta-catenin/tcf-4 Pathway And Cancer Treatment Agents
App 20090004185 - VENKATESAN; Aranapakam M. ;   et al.
2009-01-01
Imidazolopyrimidine Analogs And Their Use As Pi3 Kinase And Mtor Inhibitors
App 20080233127 - Bursavich; Matthew Gregory ;   et al.
2008-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed